Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
We are having a hard time with a media release issued yesterday by BJU International in relation to a study just published in that journal by Tewari et al. (Actually, we are having a hard time with the results of the study itself too.)
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: age, follow-up, orgasm, potency, RALP, sexual function | 4 Comments »
The “New” Prostate Cancer InfoLink has long been pointing out the lack of any evidence that men who are treated with robot-assisted laparoscopic prostatectomy (RALP) will have better outcomes with respect to continence and sexual function than men who elect to have the older, ”open” form of radical prostatectomy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: continence, laparoscopic, open, outcome, prostatectomy, RALP, robot-assisted, sexual function, surgery | 12 Comments »
According to a report from Prof. Thomas Aherling on the UroToday web site, there were three interesting presentations related to nerve-sparing surgery at the recent World Conference of Endourology and SWL, in Kyoto Japan.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: nerve-sparing, outcome, radical prostatectomy, sexual function, surgery | Leave a Comment »
Many readers of The “New” Prostate Cancer InfoLink may be interested in listening to or reading the transcript of a program on Science Friday on National Public Radio that aired last Monday.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: radical prostatectomy, sex, sexual function, Treatment | 1 Comment »
A newly published report in the Journal of the American Medical Association provides data (from two large cohorts of patients) on the quality of sexual function among men undergoing first-line treatment for localized prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: brachytherapy, external beam radiation therapy, post-treatment, prediction, radical prostatectomy, sexual function | 3 Comments »
It will likely be evident to most well-informed prostate cancer patients, support group leaders, and advocates that a man with low-risk, early stage prostate cancer (“favorable histology”) is potentially a good candidate for prostate cancer surgery.
Filed under: Diagnosis, Management, Treatment | Tagged: active surveillance, continence, outcome, quality of life, RALP, robot-assisted laparoscopic prostatectomy, sexual function | Leave a Comment »
One of our regular correspondents has brought to our attention a recent article on the CureToday.com web site that deals with dating and cancer (with prostate cancer being a specific example referred to in the article).
Filed under: Living with Prostate Cancer | Tagged: conversation, dating, experience, sexual function | Leave a Comment »
Today’s news reports include commentary on studies dealing with: Whether RALP outcomes are really comparable to those from RRP Surgical expertise, surgical caseload, and pelvic lymphadenectomy in treatment of intermediate- and high-risk prostate cancer Sexual function after first-line treatment with SBRT (CyberKnife) Distinguishing true biochemical recurrence from a PSA “bounce” after 125I-based prostate brachytherapy
Filed under: Management, Treatment | Tagged: bounce, CyberKnife, ED, failure brachytherapy, LRP, lymphadenextomy, outcomes, PSA, RALP, robot-assisted laparoscopic prostatectomy, SBRT, sexual function, stereotactic body radiotherapy | Leave a Comment »
A newly published report suggests that sexual function does indeed decline after external beam radiation therapy (EBRT) for prostate cancer — but only over the first 2 years post-treatment.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, ED, erectile dysfucntion, external beam radiation therapy, sexual function | 2 Comments »
Todays news reports adddress: Surgeon and hospital volume and outcomes to radical prostatectomy Adverse events associated with the use of hypofractionated, dose-escalated, IMRT Quality of sexual function after external beam radiation therapy Percentage of positive biopsy cores and response to first-line hormone therapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: biopsy, core, EBRT, external beam radiation therapy, hormone therapy, hospital, hypofractionated, IMRT, radical prostatectomy, sexual function, surgeon, volume | Leave a Comment »
Today’s news reports include items on: Risk for prostate cancer Patient decisions about sexual functionality and prostate cancer treatment Whole gland and focal cryotherapy Testosterone replacement after prostate cancer therapy and other items.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: cryotherapy, decision process, focal, patient, risk, sexual function, testosterone replacement, Trelstar, TRT, UroCool™ | Leave a Comment »
There are a significant number of relatively long-term news items in today’s report. Of most immediate interest to the majority of prostate cancer patients and educators we include reports on: The fact that over 70 percent of cancers thought to be unilateral at biopsy turn out to be bilateral post-surgery (which has implications for focal [...]
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, curcumin, Degarelix, focal therapy, nanoparticles, PROMIS, sexual function, TRAIL | 3 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site